Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 25 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 25 samples: 7 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE248458_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1044050 and SRA study SRP473699. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 6 samples read as cases, 13 as controls.
How we read this: 7 replicated groups read from 25 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7914668 Ptch1, IgG, Control, Input
- GSM7914669 AKP, IgG, Knockout, Input
- GSM7914670 Ptch1, H3K4me3, Control, CUT&RUN, rep1 Ptch1, H3K4me3, Control…
- GSM7914671 Ptch1, H3K4me3, Control, CUT&RUN, rep2 Ptch1, H3K4me3, Control…
- GSM7914672 AKP, H3K4me3, Knockout, CUT&RUN, rep1 AKP, H3K4me3, Knockout,…
- GSM7914673 AKP, H3K4me3, Knockout, CUT&RUN, rep2 AKP, H3K4me3, Knockout,…
- GSM7914674 Ptch1, IgG, Control, Input sample
- GSM7914675 AKP, IgG, Knockout, Input sample
- GSM7914676 Ptch1, H3K27ac, Control, ChIP, rep1 Ptch1, H3K27ac, Control…
- GSM7914677 Ptch1, H3K27ac, Control, ChIP, rep2 Ptch1, H3K27ac, Control…
- GSM7914678 AKP, H3K27ac, Knockout, ChIP, rep1 AKP, H3K27ac, Knockout,…
- GSM7914679 AKP, H3K27ac, Knockout, ChIP, rep2 AKP, H3K27ac, Knockout,…
- GSM8890598 Ptch, Cerebellum, Control, RNA-seq, rep1 Ptch, Cerebellum, Contr…
- GSM8890599 Ptch, Cerebellum, Control, RNA-seq, rep2 Ptch, Cerebellum, Contr…
- GSM8890600 Ptch, Cerebellum, Control, RNA-seq, rep3 Ptch, Cerebellum, Contr…
- GSM8890601 Ptch, Cerebellum, Control, RNA-seq, rep4 Ptch, Cerebellum, Contr…
- GSM8890602 NKP, Medulloblastoma, KO, RNA-seq, rep1 NKP, Medulloblastoma, K…
- GSM8890603 NKP, Medulloblastoma, KO, RNA-seq, rep2 NKP, Medulloblastoma, K…
- GSM8890604 NKP, Medulloblastoma, KO, RNA-seq, rep3 NKP, Medulloblastoma, K…
- GSM8890605 AKP, Medulloblastoma, KO, RNA-seq, rep1 AKP, Medulloblastoma, K…
- GSM8890606 AKP, Medulloblastoma, KO, RNA-seq, rep2 AKP, Medulloblastoma, K…
- GSM8890607 AKP, Medulloblastoma, KO, RNA-seq, rep3 AKP, Medulloblastoma, K…
- GSM9000784 Ptch1, KMT2D, Control, CUT&RUN, rep 1
- GSM9000785 Ptch1, MycN, Control, CUT&RUN, rep 1
- GSM9000786 Ptch1, NCOR2, Control, CUT&RUN, rep 1
- GSE293811 Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation [RNA-seq] 10 samples shares kmt2d, medulloblastoma, phosphorylation, demethylation, heterozygous, combinatory, diminishes, vulnerable
- GSE290849 Acute intervention reveals critical roles of BAF, KMT2D and p300 in MyoD binding on enhancers 143 samples shares kmt2d
- GSE282804 KMT2D controls cerebellar granule cell differentiation by temporally activating neuronal transcriptional factor genes 18 samples shares kmt2d
- GSE237392 Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 81 samples shares kmt2d
- GSE325799 KMT2C and KMT2D amplify GRHL2-driven enhancer activation [CUT&Tag] 80 samples shares kmt2d
- GSE237390 Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 [ChIP-seq] 54 samples shares kmt2d
- GSE264514 Epigenetic and transcriptional alterations with Kmt2c and Kmt2d knockout 50 samples shares kmt2d
- GSE236370 Epigenetic and transcriptional alterations with Kmt2c and Kmt2d loss in urothelial cells 40 samples shares kmt2d
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.